Radiobrominated benzimidazole-quinoline derivatives as Platelet-derived growth factor receptor beta (PDGFR?) imaging probes.

ABSTRACT: Platelet-derived growth factor receptor beta (PDGFR?) affects in numerous human cancers and has been recognized as a promising molecular target for cancer therapies. The overexpression of PDGFR? could be a biomarker for cancer diagnosis. Radiolabeled ligands having high affinity for the molecular target could be useful tools for the imaging of overexpressed receptors in tumors. In this study, we aimed to develop radiobrominated PDGFR? ligands and evaluate their effectiveness as PDGFR? imaging probes. The radiolabeled ligands were designed by modification of 1-{2-[5-(2-methoxyethoxy)-1H- benzo[d]imidazol-1-yl]quinolin-8-yl}piperidin-4-amine (1), which shows selective inhibition profile toward PDGFR?. The bromine atom was introduced directly into C-5 of the quinoline group of 1, or indirectly by the conjugation of 1 with the 3-bromo benzoyl group. [⁷⁷Br]1-{5-Bromo-2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinoline-8-yl}piperidin-4-amine ([⁷⁷Br]2) and [⁷⁷Br]-N-3-bromobenzoyl-1-{2-[5-(2-methoxyethoxy)-1H-benzo[d]imidazol-1-yl]quinolin-8-yl}-piperidin-4-amine ([⁷⁷Br]3) were prepared using a bromodestannylation reaction. In a cellular uptake study, [⁷⁷Br]2 and [⁷⁷Br]3 more highly accumulatd in BxPC3-luc cells (PDGFR?-positive) than in MCF7 cells (PDGFR?-negative), and their accumulation was significantly reduced by pretreatment with inhibitors. In biodistribution experiments, [⁷⁷Br]2 accumulation was higher than [⁷⁷Br]3 accumulation at 1?h postinjection. These findings suggest that [⁷⁶Br]2 is more promising for positron emission tomography (PET) imaging of PDGFR? than [⁷⁶Br]3.

SUBMITTER: Effendi N 

PROVIDER: S-EPMC6039436 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature